Log in to save to my catalogue

Novel role of LLGL2 silencing in autophagy: reversing epithelial-mesenchymal transition in prostate...

Novel role of LLGL2 silencing in autophagy: reversing epithelial-mesenchymal transition in prostate...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d5c7380b5afe426091f7cdca63876bf1

Novel role of LLGL2 silencing in autophagy: reversing epithelial-mesenchymal transition in prostate cancer

About this item

Full title

Novel role of LLGL2 silencing in autophagy: reversing epithelial-mesenchymal transition in prostate cancer

Publisher

England: BioMed Central Ltd

Journal title

Biological research, 2024-05, Vol.57 (1), p.25-25, Article 25

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Prostate cancer (PCa) is a major urological disease that is associated with significant morbidity and mortality in men. LLGL2 is the mammalian homolog of Lgl. It acts as a tumor suppressor in breast and hepatic cancer. However, the role of LLGL2 and the underlying mechanisms in PCa have not yet been elucidated. Here, we investigate the role of LLGL...

Alternative Titles

Full title

Novel role of LLGL2 silencing in autophagy: reversing epithelial-mesenchymal transition in prostate cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d5c7380b5afe426091f7cdca63876bf1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d5c7380b5afe426091f7cdca63876bf1

Other Identifiers

ISSN

0717-6287,0716-9760

E-ISSN

0717-6287

DOI

10.1186/s40659-024-00499-w

How to access this item